ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Berkshire Headlines a Busy Week for Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Today's calendar is heavy. Moderna ($103B market cap) posts results this morning. The vaccine maker's quarter has drawn attention after ORTEX Alt Data shows European plug-in hybrid registrations hit a six-year October low of 5,427 vehicles, a backdrop that underscores wider consumer-spending caution.

Humana also reports today. Medicare Advantage penetration reached a record 51.1% in July 2026, up from 50.97% a year earlier, the highest reading since tracking began in 2013. Total Medicare beneficiaries hit 70.7 million. That structural tailwind sits directly behind Humana's core business.

Energy dominates the rest of today's slate. EOG Resources, Devon Energy, and Vistra Corp all report. Power and oil names have been among the more watched S&P 500 names this quarter.

Charter Communications also releases numbers today, testing whether the cable sector's subscriber trends have stabilised.

Saturday brings the most anticipated print of the week. Berkshire Hathaway releases earnings on 7 November. Investors will parse Warren Buffett's latest moves in cash and equities.

Monday brings another cluster. Occidental Petroleum, Constellation Energy, Take-Two Interactive, and Skydance Corporation all report. Ferguson Enterprises also posts Monday morning.

Cisco Systems and Applied Materials close the week on Wednesday, 11 November. Both carry large market caps and wide analyst coverage. No IPOs are scheduled in the next seven days.

Stocks in this article

How this article was generated

Generated
6 Nov 2026, 00:31
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.